SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

ALVES, Crésio de Aragão Dantas; AGUIAR, Renata Arruti; ALVES, Ana Cláudia S  and  SANTANA, Maria Angélica. Diabetes melito: uma importante co-morbidade da fibrose cística. J. bras. pneumol. [online]. 2007, vol.33, n.2, pp.213-221. ISSN 1806-3713.

    1. Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros. 2004;3(4):209-22. [ Links ]

    2. Spence C. Cystic fibrosis-related diabetes: practice challenges. Paediatr Nurs. 2005;17(2):23-6. [ Links ]

    3. Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab. 2005;31(3 pt 1):221-32. [ Links ]

    4. Rozov T, Cunha MT, Nascimento O, Quittner AL, Jardim JR. Validação lingüística dos questionários de qualidade de vida em fibrose cística. J Pediatr (Rio J). 2006;82(2):151-6. [ Links ]

    5. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J. Pediatr. 1998;132(4):589-95. [ Links ]

    6. Alvarez AE, Ribeiro AF, Hessel G, Bertuzzo CS, Ribeiro JD. Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity. J Pediatr (Rio J). 2004;80(5):371-9. [ Links ]

    7. Mickle JE, Cutting GR. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. Clin Chest Med. 1998;19(3):443-58. [ Links ]

    8. Hadjiliadis D, Madill J, Chaparro C, Tsang A, Waddell TK, Singer LG, et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clin Transplant. 2005;19(6):773-8. [ Links ]

    9. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr. 2005;146(5):681-7. [ Links ]

    10. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Euro J Endocrinol. 2003;149(1):53-9. [ Links ]

    11. Lanng S. Glucose intolerance in cystic fibrosis patients. Pediatr Resp Rev. 2001;2(3):253-9. [ Links ]

    12. Castellanos RB, Blanco AC, García EG, Cañadell MG, Torres JFM, Calvo MTM. Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis. An Esp Pediatr. 2000;53(6):573-9. [ Links ]

    13. Mackie AD, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med. 2003;20(6):425-36. [ Links ]

    14. Dobson L, Sheldon CD, Hattersley AT. Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency. J R Soc Med. 2004;97 Suppl 44:S26-S35. [ Links ]

    15. Jensen P, Johansen HK, Lanng S, Hoybi N. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Pediatr Res. 2001;49(3):423-8. [ Links ]

    16. Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madesen HO, Schwartz M, et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr. 1993;82(2):150-4. [ Links ]

    17. Moran A. Diagnosis, screening and management of cystic fibrosis-related diabetes. Curr Diab Rep. 2002;2(2):111-5. [ Links ]

    18. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991;118(5):715-23. [ Links ]

    19. Moran A, Milla C. Abnormal glucose tolerance in cystic fibrosis: Why should patients be screened? J Pediatric. 2003;142(2):97 -9. [ Links ]

    20. Castro FA, Fernandes MI, Junior RM, Foss MC. Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis. J Pediatr (Rio J). 2001;77(4):321-6. [ Links ]

    21. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alfa: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87-91. [ Links ]

    22. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-alfa antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes. 1996;45(7):881-5. [ Links ]

    23. Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanism of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab. 2001;281(5):E1022-8. [ Links ]

    24. Hardin DS, Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am. 1999;28(4):787-800, ix. [ Links ]

    25. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Resp Crit Care Medicine. 2000;162(3 Pt 1):891-5. [ Links ]

    26. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica. 1994;83(8):849-53. [ Links ]

    27. Rozov T. Mucoviscidose (Fibrose Cística do Pâncreas). In: Rozov T, editor. Doenças Pulmonares em Pediatria. São Paulo: Atheneu; 1999. p. 443-59. [ Links ]

    28. Moran A. Endocrine complications of cystic fibrosis. Adolesc Med. 2002;13(1):145-59, vii-viii. [ Links ]

    29. Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, et al. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr. 2005;81(2):421-6. [ Links ]

    30. Azzopardi K, Lowes L. Management of cystic fibrosis-related diabetes in adolescence. Br J Nurs.2003;12(6):359-63. [ Links ]

    31. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr. 2003;142(2):128-32. [ Links ]

    32. Scott AI, Clarke BE, Healy H, D Emen M, Bell SC. Microvascular complications in cystic fibrosis-related diabetes: a case report. JOP. 2000;1(4):208-10. [ Links ]

    33. Dobson L, Stride A, Bingham C, Elworthy S, Sheldon CD, Hattersley AT. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol. 2005;39(2):103-7. [ Links ]

    34. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care. 2005;28(9):2141-4. [ Links ]

    35. Lombardi F, Raia V, Spagnuolo MI, Nugnes R, Valério G, Ciccarelli G, et al. Diabetes in an infant with cystic fibrosis. Pediatric Diabetes. 2004;5(4):199-201. [ Links ]

    36. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002;87(5):430-1. [ Links ]

    37. Starkman F, Das S. Cystic fibrosis presenting as new onset diabetes mellitus in adolescent twins. Pediatr Diabetes. 2004;5(2):99-101. [ Links ]

    38. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest. 2004;126(4):1215-24. [ Links ]

    39. Moran A, Phillips J, Milla C. Insulin and glucose excursion following pre-meal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care. 2001;24(10):1706-10. [ Links ]

    40. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eu Respir J. 2005;25(4):715-17. [ Links ]

    41. Moran A. Cystic fibrosis-related diabetes: an approach to diagnosis and management. Pediatr Diabetes. 2000;1(1):41-8. [ Links ]